Assessing the Effectiveness and Safety of Low-Dose Oral Minoxidil in Androgenetic Alopecia: A 24-Week Clinical Study

    March 2025 in “ International Journal of Scientific Research ”
    T. K. Ghosh, Projna Biswas, Chikoti Priyanka … Saswati Halder
    Studysummary This study found that low-dose oral minoxidil effectively increased hair count over 24 weeks with mild reductions in blood pressure and minimal adverse effects among participants, suggesting its potential as a safe treatment for hair loss.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on worldwidejournals.com →
    Discuss this study in the Community →

    Related research 6

    1. Tolerance and Safety Profile of Sublingual Minoxidil in the Treatment of Androgenic Alopecia Actas Dermo-Sifiliográficas · 2024
    2. Efficacy and Safety of Microneedling Radiofrequency in Patterned Hair Loss Journal of Cutaneous and Aesthetic Surgery · 2024
    3. Efficacy and Safety of Low-Dose Oral Minoxidil in the Management of Androgenetic Alopecia Expert Opinion on Pharmacotherapy · 2024
    4. Minoxidil Sulfotransferase Enzymatical Activity in Plants: A Novel Paradigm in Increasing Minoxidil Response in Androgenetic Alopecia Journal of Cosmetic Dermatology · 2023
    5. The Use of Minoxidil in the Treatment of Male and Female Androgenetic Alopecia: A Story of More Than 30 Years Italian journal of dermatology and venereology · 2018
    6. A Randomized Clinical Trial of 5% Topical Minoxidil Versus 2% Topical Minoxidil and Placebo in the Treatment of Androgenetic Alopecia in Men Journal of The American Academy of Dermatology · 2002